These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6210141)

  • 1. Effects of dose and duration of exposure on 5-aza-2'-deoxycytidine cytotoxicity for L1210 leukemia in vitro.
    Covey JM; Zaharko DS
    Cancer Treat Rep; 1984 Dec; 68(12):1475-81. PubMed ID: 6210141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the in vitro cytotoxicity (L1210) of 5-aza-2'-deoxycytidine with its therapeutic and toxic effects in mice.
    Covey JM; Zaharko DS
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):109-17. PubMed ID: 2578963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS; Ramonas LM
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
    Grant S; Rauscher F; Margolin J; Cadman E
    Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-aza-2'-deoxycytidine in combination with the biochemical modulator thymidine or the immune modulator pyran copolymer on L1210 leukemia-bearing mice.
    Zaharko DS; Covey JM
    Cancer Treat Rep; 1984 Oct; 68(10):1255-64. PubMed ID: 6084549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo.
    Veselý J; Pískala A
    Cancer Res; 1984 Nov; 44(11):5165-8. PubMed ID: 6207913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro.
    Jackson DV; Bender RA
    Cancer Res; 1979 Nov; 39(11):4346-9. PubMed ID: 291476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental chemotherapy (L1210) with 5-aza-2'-deoxycytidine in combination with pyran copolymer (MVE-4), an immune adjuvant.
    Zaharko DS; Covey JM; Muneses CC
    J Natl Cancer Inst; 1985 Jun; 74(6):1319-24. PubMed ID: 2582176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.
    Traganos F; Evenson DP; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1980 Mar; 40(3):671-81. PubMed ID: 6162553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous infusion of 5-aza-2'-deoxycytidine on survival time of mice with L1210 leukemia.
    Momparier RL; Gonzales FA
    Cancer Res; 1978 Sep; 38(9):2673-8. PubMed ID: 79443
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.
    Chlebowski RT; Dietrich M; Akman S; Block JB
    Cancer Treat Rep; 1985 May; 69(5):527-32. PubMed ID: 4005875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer.
    Lemaire M; Chabot GG; Raynal NJ; Momparler LF; Hurtubise A; Bernstein ML; Momparler RL
    BMC Cancer; 2008 May; 8():128. PubMed ID: 18454857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; Veselý J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukemic activity of 5-aza-2'-deoxycytidine and cytarabine against intracerebral L1210 murine leukemia.
    Chabot GG; Momparler RL
    Cancer Treat Rep; 1984 Dec; 68(12):1483-7. PubMed ID: 6210142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
    Presant CA; Valeriote F; Vietti TJ
    Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC).
    Stegmann AP; Honders MW; Willemze R; Landegent JE
    Leukemia; 1995 Jun; 9(6):1032-8. PubMed ID: 7541096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.